Bispecifics in Multiple Myeloma: Dosing and Transition of Care : vimarsana.com

A brief review of logistical considerations that play a part in selecting novel therapy for patients with multiply relapsed multiple myeloma.

Related Keywords

, Evolving Treatment Paradigm , Multiple Myeloma , Recent Updates , Myeloma Cancer , Relapsed Refractory Multiple Myeloma , Multiply Relapsed , Later Line Treatment , Later Line Therapy , Fixed Duration Therapy , Duration Of Therapy , Duration Of Treatment , Step Up Dosing , Priming Doses , Dose Schedule , Dosing Schedule , Access To Care , Healthcare Access , Healthcare Equity , Asco 2023 , Asco Annual Meeting ,